AstraZeneca has admitted that its COVID-19 vaccine can cause deadly blood clots, a disclosure that comes three years after the vaccine's rollout. This admission has sparked discussions on vaccine safety and effectiveness, with the New York Times highlighting the lack of a national vaccine registry in the U.S. and the censorship of individuals reporting vaccine injuries. The announcement has raised concerns about pharmaceutical companies' transparency and the need for a more robust vaccine surveillance system.
- News Machine